Medical Cannabis Advocacy in East Asia During the 1960s

The short answer

There was no meaningful organized medical cannabis advocacy movement in East Asia during the 1960s. Strong evidence

The decade in East Asia was defined by the opposite trend: consolidation of postwar prohibition regimes, alignment with the 1961 UN Single Convention on Narcotic Drugs ^[1], and — in mainland China — the Cultural Revolution, which foreclosed any independent civil-society drug policy debate. Claims that the American or European counterculture had an East Asian analogue focused on medical cannabis are not supported by the primary record.

Japan: the Taima Torishimari Hō framework

Japan's Cannabis Control Act (大麻取締法, Taima Torishimari Hō) was enacted in 1948 during the U.S. occupation and remained the governing statute throughout the 1960s ^[2]. It criminalized cultivation, possession, and transfer of cannabis outside of licensed industrial hemp farming, and — notably — did not include a medical use provision, unlike the parallel Narcotics Control Act which permitted medical opioids ^[2].

Throughout the 1960s, Japanese enforcement focused on suppressing residual traditional hemp cultivation and interdicting cannabis linked to U.S. military personnel stationed in Japan and Okinawa. Arrest numbers were small by later standards but trending upward. There is no record of a domestic Japanese organization, medical society, or public figure campaigning for medical cannabis access during this decade. Strong evidence

The romanticized narrative of Japan as a country with a deep folk-medical cannabis tradition — sometimes invoked to imply 1960s advocacy — conflates pre-Meiji folk uses of hemp (taima, asa) with modern medical cannabis, which are distinct claims. Hemp fiber and seed had ritual and agricultural roles ^[3]; documented internal-medicine use of cannabis inflorescence in early-modern Japan is thin, and no 1960s revival movement is documented. Disputed

South Korea and Taiwan

South Korea did not pass its dedicated Cannabis Control Act until 1976, but cannabis was already regulated under earlier narcotics statutes during the 1960s, and cultural attitudes under the Park Chung-hee government were sharply anti-drug ^[4]. The well-known Korean cannabis crackdown associated with musicians like Shin Joong-hyun occurred in the mid-1970s, not the 1960s, and it was a prosecution wave, not an advocacy movement ^[4].

Taiwan under martial law similarly offered no political space for drug-policy advocacy of any kind during the 1960s. Cannabis fell under the Statute for Narcotics Hazard Control framework, and public debate on liberalization was not possible under the conditions of the White Terror period.

Mainland China during the Cultural Revolution

The People's Republic of China spent most of the 1960s consumed by the Cultural Revolution (1966–1976). Independent medical societies, patient advocacy groups, and reform journalism did not exist in any form that could produce a cannabis policy debate. China did continue licensed cultivation of industrial hemp (huoma, 火麻) for fiber and of hemp seed (huomaren, 火麻仁) as a traditional Chinese medicine laxative listed in the official pharmacopoeia ^[5]. This is a continuation of centuries-old materia medica practice, not 1960s medical cannabis advocacy — the two are frequently conflated in popular writing. Disputed

How the myth of 1960s East Asian advocacy spreads

Three recurring conflations produce the false impression of 1960s East Asian medical cannabis advocacy:

1. Traditional herbal use is retroactively labeled 'advocacy.' The presence of hemp seed in Chinese pharmacopoeias, or of asa in Japanese Shinto ritual, is cited as if it were a modern reform position. It isn't. Anecdote
2. Western counterculture is projected outward. Because the U.S. and parts of Western Europe saw cannabis-linked youth movements in the 1960s ^[6], writers sometimes assume East Asia had parallel movements. Primary sources — Japanese newspaper archives, Korean legal history, PRC state media — do not show this. Strong evidence
3. Later reform figures are backdated. Japan's small modern medical cannabis reform community, which became visible in the 2010s and led to the 2023 amendment of the Cannabis Control Act permitting cannabis-derived medicines ^[7], is sometimes described as having 'roots in the 1960s.' No documented organizational lineage supports this.

If you encounter a specific claim about a 1960s East Asian medical cannabis campaign, ask for the primary source: a newspaper article, a petition, a legislative record, a named organization. In our research for this entry we did not find one.

What we don't know

There may be individual physicians, patients, or writers in 1960s Japan, Korea, Taiwan, or Hong Kong who privately advocated medical cannabis and whose writings have not been digitized or translated. Absence of evidence in English-language and major Japanese-language sources is not proof of absence. If a reader has verifiable primary sources — a dated publication, an identifiable author, a preserved document — we would revise this entry. Until then, the accurate summary is: no known organized medical cannabis advocacy in East Asia during the 1960s. No data

Sources

How this page was made